Showing results (381-390 of 392) with videos related to

Sort By:
Pageof 40
International Journal of Biological Macromolecules|July 9, 2022
Recent advances on biomedical applications of pectin-containing biomaterialsReza Eivazzadeh-Keihan, Ehsan Bahojb Noruzi, Hooman Aghamirza Moghim Aliabadi, et al.
Scientific Reports|January 3, 2024
Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure-activity relationship studiesHaleh Hamedifar, Mahroo Mirfattahi, Minoo Khalili Ghomi, et al.
Scientific Reports|February 8, 2022
Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agentsMarzieh Sohrabi, Mohammad Nazari Montazer, Sara Moghadam Farid, et al.
RSC Advances|June 28, 2023
Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamidesSajedeh Safapoor, Mohammad Halimi, Minoo Khalili Ghomi, et al.
Scientific Reports|July 2, 2025
Design, synthesis, and anti-urease evaluations of new sulfonamide-1,2,3-triazole-acetamide derivativesShohreh Bakhshi Varzaneh, Amir Shervin Shokouhi Asl, Mohammad Hosein Sayahi, et al.
International Journal of Biological Macromolecules|October 12, 2023
Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's diseaseMilad Noori, Navid Dastyafteh, Sajedeh Safapoor, et al.
Nanoscale Advances|June 15, 2026
Nanoporous-based biomaterials in biomedical applications: from fundamentals and biosensing to drug delivery, wound healing, and tissue engineeringZahra Saadatidizaji, Iman Zare, Mingzhen Zhang, et al.
Chemistry & Biodiversity|June 8, 2022
Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin-4(3H)-One Containing Different Aryl Acetohydrazides as Tyrosinase InhibitorsMirhamed Hajimiri, Mohammad Khosravikia, Mehdi Khoshneviszadeh, et al.
European Journal of Medicinal Chemistry|March 20, 2024
Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic propertiesMinoo Khalili Ghomi, Milad Noori, Maryam Mirahmad, et al.
Molecular Diversity|January 24, 2015
Synthesis and cytotoxic activity of novel poly-substituted imidazo[2,1-c][1,2,4]triazin-6-aminesTahmineh Akbarzadeh, Saeedeh Noushini, Somayeh Taban, et al.
Pageof 40